IPA Annual Working Capital
$2.46 M
-$5.50 M-69.09%
30 April 2024
Summary:
As of January 23, 2025, IPA annual working capital is $2.46 million, with the most recent change of -$5.50 million (-69.09%) on April 30, 2024. During the last 3 years, it has fallen by -$32.39 million (-92.94%). IPA annual working capital is now -92.94% below its all-time high of $34.85 million, reached on April 30, 2021.IPA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPA Quarterly Working Capital
$66.90 K
+$178.10 K+160.16%
31 October 2024
Summary:
As of January 23, 2025, IPA quarterly working capital is $66.90 thousand, with the most recent change of +$178.10 thousand (+160.16%) on October 31, 2024. Over the past year, it has increased by +$178.10 thousand (+160.16%). IPA quarterly working capital is now -99.81% below its all-time high of $34.85 million, reached on April 30, 2021.IPA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPA Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -69.1% | +160.2% |
3 y3 years | -92.9% | +160.2% |
5 y5 years | +144.8% | +160.2% |
IPA Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -92.9% | at low | -99.8% | +160.2% |
5 y | 5-year | -92.9% | +1591.2% | -99.8% | +140.6% |
alltime | all time | -92.9% | +777.6% | -99.8% | +118.4% |
ImmunoPrecise Antibodies Working Capital History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $66.90 K(-160.2%) |
July 2024 | - | -$111.20 K(-104.5%) |
Apr 2024 | $2.46 M(-69.1%) | $2.46 M(-44.8%) |
Jan 2024 | - | $4.45 M(-21.7%) |
Oct 2023 | - | $5.69 M(-18.9%) |
July 2023 | - | $7.02 M(-11.9%) |
Apr 2023 | $7.96 M(-63.4%) | $7.96 M(-12.8%) |
Jan 2023 | - | $9.13 M(-19.2%) |
Oct 2022 | - | $11.30 M(-32.6%) |
July 2022 | - | $16.76 M(-23.0%) |
Apr 2022 | $21.77 M(-37.5%) | $21.77 M(-16.9%) |
Jan 2022 | - | $26.19 M(-10.9%) |
Oct 2021 | - | $29.38 M(-8.8%) |
July 2021 | - | $32.22 M(-7.5%) |
Apr 2021 | $34.85 M(<-9900.0%) | $34.85 M(+158.2%) |
Jan 2021 | - | $13.50 M(+11.3%) |
Oct 2020 | - | $12.12 M(+201.4%) |
July 2020 | - | $4.02 M(-2537.8%) |
Apr 2020 | -$165.00 K(-116.4%) | -$165.00 K(-119.1%) |
Jan 2020 | - | $862.80 K(+41.4%) |
Oct 2019 | - | $610.10 K(-43.3%) |
July 2019 | - | $1.08 M(+7.0%) |
Apr 2019 | $1.00 M(+159.0%) | $1.00 M(-81.1%) |
Jan 2019 | - | $5.32 M(-14.7%) |
Oct 2018 | - | $6.24 M(+1374.0%) |
July 2018 | - | $423.40 K(+9.1%) |
Apr 2018 | $388.00 K(-78.4%) | $388.00 K(-76.8%) |
Jan 2018 | - | $1.67 M(-36.3%) |
Oct 2017 | - | $2.63 M(+95.8%) |
July 2017 | - | $1.34 M(-25.2%) |
Apr 2017 | $1.80 M(-1127.0%) | $1.80 M(-30.3%) |
Jan 2017 | - | $2.57 M(+1118.9%) |
Sept 2016 | - | $211.20 K(-224.3%) |
June 2016 | - | -$169.90 K(-6.4%) |
Mar 2016 | - | -$181.60 K(+3.9%) |
Dec 2015 | -$174.80 K(-4.1%) | - |
Dec 2015 | - | -$174.80 K(+5.6%) |
Sept 2015 | - | -$165.60 K(-2.5%) |
June 2015 | - | -$169.90 K(-1.1%) |
Mar 2015 | - | -$171.80 K(-5.7%) |
Dec 2014 | -$182.20 K(+17.4%) | - |
Dec 2014 | - | -$182.20 K(-8.6%) |
Sept 2014 | - | -$199.30 K(+12.2%) |
June 2014 | - | -$177.70 K(+21.4%) |
Mar 2014 | - | -$146.40 K(-5.7%) |
Dec 2013 | -$155.20 K(-30.2%) | - |
Dec 2013 | - | -$155.20 K(+50.0%) |
Sept 2013 | - | -$103.50 K(-57.5%) |
June 2013 | - | -$243.60 K(+4.6%) |
Mar 2013 | - | -$232.90 K(+4.8%) |
Dec 2012 | -$222.20 K(+79.2%) | - |
Dec 2012 | - | -$222.20 K(+28.4%) |
Sept 2012 | - | -$173.00 K(+17.2%) |
June 2012 | - | -$147.60 K(+10.9%) |
Mar 2012 | - | -$133.10 K(+7.3%) |
Dec 2011 | -$124.00 K(-182.1%) | - |
Dec 2011 | - | -$124.00 K(+52.3%) |
Sept 2011 | - | -$81.40 K(-554.7%) |
June 2011 | - | $17.90 K(-85.4%) |
Mar 2011 | - | $122.50 K(-18.9%) |
Dec 2010 | $151.10 K | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | - | $151.10 K(-214.9%) |
Sept 2010 | - | -$131.50 K(+120.6%) |
June 2010 | - | -$59.60 K(+338.2%) |
Mar 2010 | - | -$13.60 K(-129.0%) |
Dec 2009 | $46.90 K(-90.2%) | - |
Dec 2009 | - | $46.90 K(-63.4%) |
Sept 2009 | - | $128.00 K(-21.0%) |
June 2009 | - | $162.10 K(-25.8%) |
Mar 2009 | - | $218.50 K(-54.6%) |
Dec 2008 | $480.80 K(+4.5%) | - |
Dec 2008 | - | $480.80 K(-51.4%) |
Sept 2008 | - | $989.00 K(+364.8%) |
June 2008 | - | $212.80 K(-29.1%) |
Mar 2008 | - | $300.00 K(-34.8%) |
Dec 2007 | $460.10 K(+980.0%) | - |
Dec 2007 | - | $460.10 K(+8.8%) |
Sept 2007 | - | $422.70 K(+24.8%) |
June 2007 | - | $338.70 K(+1439.5%) |
Mar 2007 | - | $22.00 K(-48.4%) |
Dec 2006 | $42.60 K(-90.9%) | - |
Dec 2006 | - | $42.60 K(-92.9%) |
Sept 2006 | - | $603.10 K(-64.2%) |
June 2006 | - | $1.68 M(+346.2%) |
Mar 2006 | - | $377.40 K(-19.7%) |
Dec 2005 | $470.00 K(-77.6%) | - |
Dec 2005 | - | $470.00 K(-23.1%) |
Sept 2005 | - | $611.00 K(-57.8%) |
June 2005 | - | $1.45 M(-24.5%) |
Mar 2005 | - | $1.92 M(-8.6%) |
Dec 2004 | $2.10 M(+338.2%) | - |
Dec 2004 | - | $2.10 M(+272.7%) |
Sept 2004 | - | $563.30 K(-30.9%) |
June 2004 | - | $815.30 K(-9.1%) |
Mar 2004 | - | $896.60 K(+87.1%) |
Dec 2003 | $479.10 K(+4597.1%) | - |
Dec 2003 | - | $479.10 K(+79.2%) |
Sept 2003 | - | $267.40 K(<-9900.0%) |
June 2003 | - | -$1400.00(-103.5%) |
Mar 2003 | - | $40.30 K(+295.1%) |
Dec 2002 | $10.20 K(-111.8%) | - |
Dec 2002 | - | $10.20 K(-66.1%) |
Sept 2002 | - | $30.10 K(-43.8%) |
June 2002 | - | $53.60 K(-142.4%) |
Mar 2002 | - | -$126.40 K(+46.3%) |
Dec 2001 | -$86.40 K(-76.2%) | - |
Dec 2001 | - | -$86.40 K(-7.7%) |
Sept 2001 | - | -$93.60 K(-577.6%) |
June 2001 | - | $19.60 K(-105.9%) |
Mar 2001 | - | -$333.40 K(-8.2%) |
Dec 2000 | -$363.10 K(-282.7%) | - |
Dec 2000 | - | -$363.10 K(-670.9%) |
Sept 2000 | - | $63.60 K(-54.4%) |
June 2000 | - | $139.40 K(-17.1%) |
Mar 2000 | - | $168.10 K(-15.4%) |
Dec 1999 | $198.70 K(-35.1%) | - |
Dec 1999 | - | $198.70 K(-35.1%) |
Dec 1998 | $306.10 K(-57.9%) | - |
Dec 1998 | - | $306.10 K(-57.9%) |
Dec 1997 | $727.80 K(-57.6%) | - |
Dec 1997 | - | $727.80 K |
Dec 1996 | $1.72 M | - |
FAQ
- What is ImmunoPrecise Antibodies annual working capital?
- What is the all time high annual working capital for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual working capital year-on-year change?
- What is ImmunoPrecise Antibodies quarterly working capital?
- What is the all time high quarterly working capital for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?
What is ImmunoPrecise Antibodies annual working capital?
The current annual working capital of IPA is $2.46 M
What is the all time high annual working capital for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual working capital is $34.85 M
What is ImmunoPrecise Antibodies annual working capital year-on-year change?
Over the past year, IPA annual working capital has changed by -$5.50 M (-69.09%)
What is ImmunoPrecise Antibodies quarterly working capital?
The current quarterly working capital of IPA is $66.90 K
What is the all time high quarterly working capital for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly working capital is $34.85 M
What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?
Over the past year, IPA quarterly working capital has changed by +$178.10 K (+160.16%)